Parkinson's Discovery Suggests We May Alr... - Cure Parkinson's

Cure Parkinson's

25,901 members27,214 posts

Parkinson's Discovery Suggests We May Already Have an FDA-Approved Treatment

pvw2 profile image
pvw2
7 Replies

sciencealert.com/parkinsons...

"Promisingly, an FDA-approved cancer drug that targets another protein called Lag3 – which interacts with Aplp1 – blocks the spread in mice, suggesting a potential therapy may already exist."

Written by
pvw2 profile image
pvw2
To view profiles and participate in discussions please or .
7 Replies
pmmargo profile image
pmmargo

link.springer.com/article/1...

pmmargo profile image
pmmargo

Im sorry to repost. You are the first to spot this. And. this is big!

jeffreyn profile image
jeffreyn

See also this earlier thread:

healthunlocked.com/cure-par...

Boscoejean profile image
Boscoejean

this treatment is expensive:

"A 20 mL vial of nivolumab 240 mg plus relatlimab 80 mg, a fixed-dose combination, can cost around $8,315, with a treatment cost of $16,630 every 28 days. However, the price may vary depending on the pharmacy, and quoted prices are usually for cash-paying customers and are not valid with insurance plans. Drugs.com offers a price guide based on using their discount card, which is accepted at most U.S. pharmacies"

Boscoejean profile image
Boscoejean

Looks like more mouse studies before any human clinical trials.

"As of June 2024, the FDA has not approved nivolumab for Parkinson's disease, but a study suggests that it could potentially slow or stop the disease's progression in humans. The study found that nivolumab/relatlimab, an FDA-approved cancer drug, halted disease progression in mice. However, the researchers note that testing on mice differs from testing on humans, and that there are other limitations to their work. Further testing, such as human trials, could help confirm these findings."

"“The next steps would involve conducting clinical trials with the anti-Lag3 antibody drug in mouse models of Parkinson’s and Alzheimer’s diseases to further evaluate its efficacy and safety. If successful, human clinical trials would follow to assess the drug’s potential as a treatment for these neurodegenerative diseases. Additionally, [we] plan to investigate ways to prevent unhealthy brain cells from releasing disease-causing alpha-synuclein clumps in the first place, which could complement the approach of blocking their spread and uptake by healthy cells.”"

medicalnewstoday.com/articl...

gomelgo profile image
gomelgo

Two words: "in mice". I don't think it's "big" after all. When they stop wasting time, money and lives, maybe humans can get a fair shake. Mice don't randomly get parkinson's. Only humans do.

Eryl profile image
Eryl

That's if you still believe that proteins are the cause of PD rather than the result of PD i.i the body producing the protein to patch up damage done by something else.

You may also like...

FDA Approves Focused Ultrasound Treatment for Parkinson’s Disease

https://www.fusfoundation.org/news/fda-approves-focused-ultrasound-treatment-for-parkinsons-disease

Overnight the FDA was approving clinical trials for treatments for the Corona virus. Why can’t it work on Parkinson's at the same pace

seemed as if overnight the FDA was approving clinical trials for treatments for the virus. Why...

We can change the course of Parkinson's treatments.

million! waiting to be heard. If we pick our target, treatments in time for us, we can find a...

Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease

-of-buntanetap-for-the-treatment-of-parkinsons-disease-301741593.html...

Approved Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson's Disease Patients Worldwide in Japan

https://www.bignewsnetwork.com/news/274040185/stem-cell-therapy-developed-in-korea-begins-treatment-